Athelas develops technology to monitor chronically ill patients in their homes.
Athelas develops technology to monitor chronically ill patients in their homes. The company has deployed an FDA-cleared blood diagnostic device along with an array of other sensors to manage Blood Pressure, Weight, Glucose, and Medication Adherence.
| Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
|---|---|---|---|---|---|---|
| Jan 31, 2022 | Series Unknown | $59.43M | 7 |
Tribe Capital
|
— | Detail |
| Aug 10, 2021 | Series B | $72M | 2 |
General Catalyst
|
— | Detail |
| Feb 1, 2019 | Series A | $15M | 2 |
Georges Harik
|
— | Detail |
| Aug 28, 2017 | Seed | $3.70M | 11 |
Sequoia Capital
|
— | Detail |
|
Date
Company Name
|
Round | Money Raised | Industry | Lead Investor |
|---|---|---|---|---|
|
Jul 11, 2022
Klarna
|
Series Unknown | $800M | E-Commerce | — |
|
Apr 8, 2019
Klarna
|
Private Equity(PE) | $93M | E-Commerce | — |
|
Mar 14, 2014
Klarna
|
Series Unknown | €90M | E-Commerce | — |
| Investor Name | Lead Investor | Funding Round |
|---|---|---|
Tribe Capital
|
Yes | Series Unknown |
General Catalyst
|
Yes | Series B |
Georges Harik
|
Yes | Series A |
Sequoia Capital
|
— | Series Unknown |
Fifty Years
|
— | Series Unknown |
Greenoaks
|
— | Series Unknown |
Human Capital
|
— | Series Unknown |
Initialized Capital
|
— | Series Unknown |
Y Combinator
|
— | Series Unknown |
CJ Reim
|
— | Seed |